NASDAQ:MGTX 10 November 2025

MeiraGTx Falls 5.5% as MGTX Shares Slip, Investors Keep Watch Next Week

MeiraGTx Holdings plc is under pressure early this week after a late Friday slide knocked back most of its recent gains from pipeline news and funding headlines. The stock closed at $9.40 on Friday, down 5.5% for the day and 4.3% over the last five sessions, market data shows.

17 May 2026

Biotechnology·NASDAQ:MGTX·Stock Market

Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

Eli Lilly and Company opened the week with a burst of dealmaking and Wall Street momentum. The pharma giant announced a rights deal for a pediatric blindness gene therapy from MeiraGTx, unveiled a new AI‑driven discovery partnership, and captured an analyst upgrade with a higher price target—moves that had LLY trading sharply higher intraday. Reuters+2

10 November 2025

Artificial Intelligence·NASDAQ:ADVM·NASDAQ:MGTX·NASDAQ:NVDA·NYSE:LLY·Pharmaceuticals·Stock Market

NASDAQ:MGTX 10 November 2025 - 17 May 2026

MeiraGTx Falls 5.5% as MGTX Shares Slip, Investors Keep Watch Next Week

Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

TechStock² Updates

Trump Extends Jones Act Waiver 90 Days, Shifts to Voyage-by-Voyage Reviews

Hims & Hers Shares Drop After Beating Revenue Forecast With $753 Million, Margins Narrow

Gold Climbs to Highest Level in Nine Weeks as Renewed Chinese Demand Revives $4,500 Target

HPE Shares Climb Following Morgan Stanley Upgrade, With $71 Price Target Indicating 30% Upside

Silence Therapeutics Jumps Over 25% After Divesiran Phase 2 Trial Supports 12-Week Dosing

Top Stock Picks

Taiwan Semiconductor

AerCap

Constellation Energy

Walt Disney

American International Group

Live updates

Investment Disclaimer